Dual hypoxia-responsive supramolecular complex for cancer target therapy

The prognosis with pancreatic cancer is among the poorest of any human cancer. One of the important factors is the tumor hypoxia. Targeting tumor hypoxia is considered a desirable therapeutic option. However, it has not been translated into clinical success in the treatment of pancreatic cancer. Wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jian-Shuang, Li, Juan-Juan, Wang, Ze-Han, Liu, Yang, Yue, Yu-Xin, Li, Hua-Bin, Zhao, Xiu-He, Sun, Yuan-Jun, Ding, Ya-Hui, Ding, Fei, Guo, Dong-Sheng, Wang, Liang, Chen, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500001/
https://www.ncbi.nlm.nih.gov/pubmed/37704601
http://dx.doi.org/10.1038/s41467-023-41388-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500001/
https://www.ncbi.nlm.nih.gov/pubmed/37704601
http://dx.doi.org/10.1038/s41467-023-41388-2

Ejemplares similares